Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
07 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/07/3076720/0/en/Ashvattha-Therapeutics-to-Present-Positive-Phase-2-Results-for-Subcutaneous-Migaldendranib-in-Retinal-Vascular-Disease-at-ARVO.html
15 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/15/3061682/0/en/Ashvattha-Therapeutics-to-Present-at-ARVO-Retina-World-Congress-and-AOS-Annual-Meeting.html
18 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2025/03/18/3044467/0/en/Ashvattha-Therapeutics-Accelerates-Clinical-Development-Strategy-with-Leadership-Appointment-of-Six-Leading-Retinal-Specialists-to-Clinical-Advisory-Board.html
10 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/10/3023403/0/en/Ashvattha-Presents-Positive-Phase-2-Data-for-Subcutaneous-Migaldendranib-at-Angiogenesis-2025-Conference.html
06 Feb 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/02/06/3022001/0/en/Ashvattha-to-Present-at-Upcoming-Angiogenesis-Exudation-and-Degeneration-2025-and-BIO-CEO-Conferences.html
13 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/13/3008491/0/en/Ashvattha-Therapeutics-Announces-50-Million-Financing-Extension-and-Interim-Phase-2-Ophthalmology-Trial-Results.html
ABOUT THIS PAGE
Ashvattha Therapeutics is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of F-OP-801 bulk with DMF offered by Ashvattha Therapeutics
Find a price of 18F-OP-801 bulk with DMF offered by Ashvattha Therapeutics